Longmont, CO, Dec. 29, 2011 (GLOBE NEWSWIRE) -- With funding from the National Institutes of Health, Synkera is actively developing ceramic ultrafiltration membranes with monodisperse pores for applications in laboratory filtration, chemical and bioanalysis, biomedical research, biomanufacturing and other sectors. The novel membrane architecture enables unprecedented sharp and controllable molecular weight cut-off (MWCO), reduced fouling, and high flux. Membranes are available in a variety of formats and pore sizes.
Key features and benefits of the membranes include:
• highly reproducible pore diameter with narrow distribution,
• sharp MWCO available in the range from below 5 to over 300 kDa,
• smooth surface and uniform pores resulting in reduced fouling,
• absolute immunity to organic solvents,
• thermal stability up to 600°C,
• good mechanical durability and resistant to abrasion,
• excellent biocompatibility and no product contamination.
About Synkera Technologies, Inc.
Synkera develops and manufactures nano/microstructured materials, components, and devices focusing on chemical sensors, ceramic ultra- and microfiltration membranes, grids for electron microscopy, composite ceramic-metal hydrogen separation membranes, nanostructured catalytic support, and templates for nanofabrication. Utilizing nanotechnology, microfabrication, and advanced materials engineering, Synkera brings practical products to the market for everyday use.
A photo accompanying this release is available at:
http://www.globenewswire.com/newsroom/prs/?pkgid=11319
